Profil bibliographique

A Chandrashekar

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

2Publications signalées

19Citations signalées

0Affiliations récentes

Les domaines associés

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmunotherapy and Immune ResponsesProtein purification and stabilityvaccines and immunoinformatics approaches

Les publications récentes

Accès ouvert 2024 article OpenAlex

Durability of Heterologous and Homologous COVID-19 Vaccine Boosts

Roy V, Hauser B.M, Powers J.M, A Chandrashekar et autres

Importance: Antibody responses elicited by current messenger RNA (mRNA) COVID-19 vaccines decline rapidly and require repeated boosting. Objective: To evaluate the immunogenicity and durability of heterologous and homologous prime-boost regimens involving the adenovirus vector vaccine Ad26.COV2.S and the mRNA vaccine BNT162b2. Design, …

us (code pays fourni par la source)

0 citations Carolina Digital Repository (University of North Carolina at Chapel Hill)

2021 dataset OpenAlex

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

G Alter, J Yu, J Liu, A Chandrashekar et autres

The Ad26.COV2.S vaccine1-3 has demonstrated clinical efficacy against symptomatic COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing antibodies1. However, the immunogenicity of this vaccine in humans against SARS-CoV-2 variants of concern remains unclear. Here we report humoral and …

19 citations immuneACCESS

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.